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ABSTRACT:Amyloidb-protein (Ab)molecules tend to aggregate and subsequently form lowMW(LMW)oligomers,
high MW (HMW) aggregates such as protofibrils, and ultimately fibrils. These Ab species can generally form
amyloid plaques implicated in the neurodegeneration ofAlzheimer disease (AD), but therapies designed to reduce
plaque load have not demonstrated clinical efficacy. Recent evidence implicates amyloid oligomers in AD neuro-
pathology, but the precisemechanisms are uncertain.We examined themechanisms of neuronal dysfunction from
HMW-Ab1-42 exposure by measuring membrane integrity, reactive oxygen species (ROS) generation, membrane
lipid peroxidation, membrane fluidity, intracellular calcium regulation, passive membrane electrophysiological
properties, and long-term potentiation (LTP). HMW-Ab1-42 disturbed membrane integrity by inducing ROS gen-
eration and lipid peroxidation, resulting in decreased membrane fluidity, intracellular calcium dysregulation,
depolarization, and impaired LTP. The damaging effects of HMW-Ab1-42 were significantly greater than those of
LMW-Ab1-42. Therapeutic reduction of HMW-Ab1-42 may prevent ADprogression by ameliorating direct neuronal
membrane damage.—Yasumoto, T., Takamura, Y., Tsuji, M., Watanabe-Nakayama, T., Imamura, K., Inoue, H.,
Nakamura, S., Inoue, T., Kimura, A., Yano, S.,Nishijo, H., Kiuchi, Y., Teplow,D. B.,Ono,K.Highmolecularweight
amyloid b1-42 oligomers induce neurotoxicity via plasma membrane damage. FASEB J. 33, 000–000 (2019).
www.fasebj.org
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Neurodegenerativediseases [e.g.,Alzheimerdisease (AD),
Parkinson disease, and spinocerebellar ataxia] have
characteristic abnormal protein aggregates in the brain. In
AD, amyloid plaques formed of amyloid b-protein (Ab)
and neurofibrillary tangles (NFTs) formed of hyper-
phosphorylated tau protein are the 2 cardinal neuropath-
ological characteristics of the postmortem AD brain (1).
Human genetic association studies, biochemical anal-
yses of AD plaque content, and various animal models
with altered Ab or tau expression strongly implicate Ab
and tau inADpathogenesis (1). Furthermore,many in vivo
and in vitro studies have demonstrated the neurotoxicity
of amyloidogenic proteins. This neurotoxicity depends
strongly on Ab primary structure and aggregation state.
For example, 2 predominant Ab forms are produced in
humans, comprising 40 (Ab1-40) or 42 (Ab1-42) amino acid
residues, but the relative proportion of Ab1-42 is particu-
larly crucial forADprogressionbecause this longer form is
more prone to undergo aggregation and is inherently
more toxic than Ab1-40 (2). Ab molecules form low MW
(LMW) oligomers and high MW (HMW) oligomers such
ABBREVIATIONS: Ab, amyloid b-protein; ACSF, artificial cerebrospinal
fluid; AD, Alzheimer disease; AFM, atomic force microscopy; DPPP,
diphenyl-1-pyrenylphosphine; fEPSP, field excitatory postsynaptic po-
tential; HEK293T, human embryonic kidney 293T; HEPES, 4-(2-
hydroxyethyl)-1-piperazineethanesulfonic acid; HFS, high-frequency
stimulation; HMW, high MW; HS-AFM, high-speed AFM; iPSC, in-
duced pluripotent stem cell; LDH, lactate dehydrogenase; LMW, low
MW; LTP, long-term potentiation; MTT, 3-(4,5-dimethylthiazoyl-2-yl)-
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channel; WST, water soluble tetrazolium
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as protofibrils (PFs) and finally form mature fibrils sug-
gested to be the primary cause of neuronal dysfunction in
AD (3). Although these Ab aggregates can possibly di-
rectly cause neuronal injury by acting on synapses or in-
directly cause it by activating astrocytes andmicroglia (2),
evidence also supports the hypothesis that intermediate
aggregates of Ab, such as oligomers, play an important
role inADpathogenesis (1, 3–6). For instance, intracerebral
injection of Ab oligomers inhibits hippocampal long-term
potentiation (LTP) in mice and rats (5, 7). Pyroglutamate-
modifiedAb1-42,which is enriched inADbrains compared
with healthy controls, has been observed to aggregate
faster than Ab1-42 by rapid formation of Ab1-42 oligomers,
resulting in enhancement of neurotoxicity of Ab1-42 (8, 9).
Inaddition,PFsare toxic to culturedneuronal cell lines and
to primary neurons, and they cause profound changes in
the electrical activity of mixed neuron-glia cultures (4). A
formof familialADhas also beendescribed that is due to a
mutation in the gene that encodes the amyloid precursor
protein resulting in the production of an Ab species,
[Glu22Gly]Ab, with high propensity to form PFs (10).
Therefore, the canonical amyloid cascade hypothesis,
positing that Ab deposition leads to the formation of am-
yloid (senile) plaques and subsequently to NFTs and
neuronal death, has been largely supplanted by the olig-
omer cascade hypothesis in which soluble oligomers are
directly neurotoxic. However, the precise mechanisms of
oligomer-mediated cytotoxicity remain incompletely un-
derstood, although evidence does suggest that the neu-
ronal cell membrane is the chief site of oligomer-mediated
neuronal damage. Membrane environment can enhance
conformational change of Ab to toxic b–sheet structure,
which serves as nucleation sites for faster self-aggregation
depending on lipid content within the membrane (11). In
addition, ganglioside-containing membranes have been
found to alter the aggregationpathways ofAb; that is, low
Ab:ganglioside ratios yield an a-helical Ab structure,
whereas an increasing Ab:ganglioside ratio promotes
fibrillization (12). On the other hand, oligomers trigger a
toxic cascade that involves the formation of ion-permeable
membrane pores (13), interference with membrane re-
ceptor activities (14), and oxidation of membrane lipids
(15). Membrane integrity is essential for maintaining cel-
lular metabolism and intracellular calcium ion homeosta-
sis, and dysregulation of these processes by Ab triggers
neuronal apoptosis (16, 17). Ab can insert directly into the
membrane and form a pore (18). Recently, using explicit
solvent molecular dynamics simulations (19), Ab oligo-
mers have been reported to insert irreversibly into a
membrane, followed by spontaneously forming ion chan-
nels, resulting in cell death. This result is consistentwith the
result that Ab1-42 can assemble into a b-barrel pore in lipid
bilayers under optimizeddetergentmicelle conditions (20).
Although most of these studies used artificial membrane
models, it was recently reported that small Ab oligomers
have higher membrane affinity than monomers in human
embryonic kidney 293T (HEK293T) cells (21).
A clearer understanding of Ab-membrane interactions
isneeded for futureADtreatmentdevelopment, especially
because disease-modifying therapies that disassemble or
remove amyloids have failed in clinical trials. In the
present study, we examined the relationship between
cellular membrane damage caused by HMW-Ab oligo-
mers and neurotoxicity using systematic in vitro, cellular,
and synaptic assays, including measures of membrane
integrity, reactive oxygen species (ROS) generation, lipid
peroxidation, membrane fluidity, intracellular calcium
concentration, membrane potentials, and LTP.
MATERIALS AND METHODS
Drugs and reagents
Highly purified human Ab1-42 was purchased from Peptide In-
stitute (Osaka, Japan), andDMEM,Ham’s F-12medium, and all-
trans-retinoic acid were procured from Wako Pure Chemicals
(Osaka, Japan). Further, fetal bovine serum, 4-(2-hydroxyethyl)-
1-piperazineethanesulfonic acid (HEPES), and EGTA were pur-
chased fromMilliporeSigma (Burlington,MA,USA). PenicillinG
sodium, streptomycin sulfate, and amphotericinBwere obtained
from Thermo Fisher Scientific (Waltham, MA, USA). The other
chemicals usedwere of the purest grade commercially available.
Water was double distilled and deionized by using Milli-Q sys-
tem (MilliporeSigma).
Preparation of Ab
Weprepared aggregate-free solutions of Ab using size exclusion
chromatography (SEC) (22, 23). Thenominalmonomer fraction is
known as LMW because it comprises monomers mainly and
dimers partly in rapid equilibrium at experimental peptide con-
centrations (22–24). To prepare LMW-Ab1-42 and HMW-Ab1-42,
Ab1-42 was dissolved in DMSO at 2 mg/ml, sonicated for 3 min,
and centrifuged for 20min at 16,000 g. Next, the supernatantwas
fractionatedusing10mMphosphatebuffer (pH7.4) at a flowrate
of 0.5 ml/min on a Superdex 75 HR column (GE Healthcare,
Waukesha, WI, USA). The HMW peak eluted at 16–17 min (im-
mediately after the column void volume) and was followed by
the LMW peak at 26–27 min (Fig. 1A). The central 60 s of the
HMW and LMW peaks were individually collected and main-
tained at 280°C. In each preparation, the peptide concentration
wasdeterminedusing theBradford-basedBio-RadProteinAssay
Dye Reagent Concentrate (Bio-Rad, Hercules, CA, USA).
Aggregate concentration referred to monomeric Ab1-42 con-
centration. Typically, the concentrations of LMW-Ab1-42 and
HMW-Ab1-42 were 17 and 12 mM, respectively.
Transmission electron microscopy
A10-ml aliquot fromeachAb1-42 fractionwasdottedontoaglow-
discharged, carbon-coated formvar grid (Okenshoji, Tokyo,
Japan) and then incubated for 20 min. Then, the droplet was
displaced with 2.5% (vol/vol) glutaraldehyde in water at an
equal volume and incubated for 5 min. Lastly, 8 ml of 1% (vol/
vol) uranyl acetate in water (Wako Pure Chemicals) was used to
stain the peptide. The residual liquid was wicked off; the grid
then was air dried, and the samples were observed using a JEM-
1210 transmissionelectronmicroscope (TEM; Jeol, Tokyo, Japan).
Atomic force microscopy
We performed tapping mode high-speed atomic force micros-
copy (HS-AFM) (25, 26) at room temperature in liquid using a
small cantilever (BL-AC10-DS; Olympus, Tokyo, Japan) with
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resonance frequency f of 400–500 kHz and a spring constant k
of 0.1 N/m. Further, an amorphous carbon tip was grown on
each cantilever by electron beam deposition with a field
emission scanning electron microscope (ERA8000-FE; STS-
Elionix, North Billerica, MA, USA). Although the free oscil-
lation amplitude was set at 1.5 nm, the set-point amplitude
was 80–90% of the free amplitude. Next, LMW-Ab1-42 or
HMW-Ab1-42 solutionwas introduced into a sample chamber,
and the HS-AFM image sequences were processed using
ImageJ software [imagej.nih.gov/ij/; National Institutes of
Health (NIH), Bethesda, MA, USA] (27).
SH-SY5Y cell culture
SH-SY5Y (EC-94030304), a human neuroblastoma cell line,
was acquired from the European Collection of Authenticated
Cell Cultures (London, United Kingdom). The cells were
cultured in DMEM and Ham’s F-12 medium that contained
10% fetal bovine serum and antibiotic-antimycotic solution,
and they were maintained under a humidified atmosphere of
5% CO2 and 95% air at 37°C. SH-SY5Y cells are similar to
neurons in terms of their morphologic and neurochemical
properties, and they have been widely used to evaluate neu-
ronal injury anddeath in response to neurotoxins and cerebral
ischemia–reperfusion as in vitro disease models (28). To
evaluate the effects of Ab1-42, SH-SY5Y cells were initially
differentiatedwith all-trans retinoic acid. In the present study,
differentiated SH-SY5Y cells were exposed to 5 mM of LMW-
Ab1-42 or HMW-Ab1-42 for 30 min under sterile conditions.
Induced pluripotent stem cell culture
The healthy human induced pluripotent stem cell (iPSC) line
201B7 was maintained using the StemFit feeder-free culture sys-
tem (Ajinomoto, Tokyo, Japan) (29). Cortical neurons were gen-
erated from iPSCs via transfection of Ngn2 using piggyBac vector
with the tet-on system as previously reported in Imamura et al.
(30). Briefly, iPSCs were dissociated to single cells with
Accumax solution (Innovative Cell Technologies, San Diego,
CA,USA) andplated onMatrigel-coated 96-well plastic plates
(BD Biosciences, San Jose, CA, USA) with a neural medium
containing 1:1 DMEM/F12 (Thermo Fisher Scientific) and
Neurobasal medium (Thermo Fisher Scientific) plus 1% N2
supplement, 2% B27 supplement, 10 ng/ml brain-derived
neurotrophic factor (R&D Systems, Minneapolis, MN, USA),
10 ng/ml glial cell-derived neurotrophic factor (R&D Sys-
tems), 10 ng/ml neurotrophin-3 (R&D Systems), and 1mg/ml
doxycycline (Takara, Kusatsu, Japan).
3-(4,5-Dimethylthiazoyl-2-yl)-2,5-
diphenyltetrazolium bromide viable cell assay
Cell viability was measured using the Cell Proliferation Kit I
(Roche, Basel, Switzerland). This assay is based on the forma-
tion of blue formazan from 3-(4,5-dimethylthiazoyl-2-yl)-2,5-
diphenyltetrazolium bromide (MTT) by mitochondrial
dehydrogenases, which are active only in live cells. We con-
ducted a preliminary experiment in which SH-SY5Y cells were
exposed to different Ab1-42 concentrations (1, 2.5, 5, and 10mM),
andwe found that 5mMwas themost suitable concentration for
inducing cytotoxicity (Supplemental Fig. S1). After exposure to
LMW-Ab1-42 orHMW-Ab1-42 for 30min, cells were treatedwith
DMSO to dissolve the formazan and formationwasmeasured at
540 nm using a microplate reader (Spectra Max i3; Molecular
Devices, Sunnyvale, CA, USA).
Lactate dehydrogenase release assay
Lytic cell death was measured using the Cytotoxicity Detection
Kit (Roche). This kit quantifies cytotoxicity/cytolysis based on
the measurement of lactate dehydrogenase (LDH) activity re-
leased into the medium when cell membrane integrity is lost.
After exposure to 5 mM of LMW-Ab1-42 or HMW-Ab1-42 for
30 min, LDH in the culture mediumwas measured according to
Figure 1. Preparation of HMW and LMW-Ab1–42 fraction. A) SEC of Ab1–42. The synthesized Ab1–42 was applied on a gel filtration
column. The HMW peak was eluted at 16–17 min followed by the LMW peak at 26–27 min. B–E) TEM (B, C) and AFM (D, E)
images of LMW-Ab1-42 (B, D) and HMW-Ab1-42 (C, E). Scale bars, 100 nm (B, C) and 100 nm (D, E). Z scale, 10 nm (D, E). F) Box
plots of LMW-Ab1-42 and HMW-Ab1-42 aggregate sizes from AFM images (D, E). The boxes extend from the 25th to 75th
percentile. The median values shown by the single bars in the boxes correspond to 3.9 nm for LMW-Ab1-42 and 5.2 nm for HMW-
Ab1-42. The whiskers extend from the minimum to the 25th percentile and from the 75th percentile to the maximum. The
asterisk indicates the statistically significant difference between LMW and HMW fractions. ***P , 0.001, U test.
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substrate conversion at 490 nm using a microplate reader
(Spectra Max i3).
Calcein and ethidium homodimer-1 (live/dead)
cell assay
Surviving and dying SH-SY5Y cells were also measured by cal-
cein and ethidium homodimer-1 costaining. Briefly, cells cul-
tured in 96-well plates were exposed to 5 mMof LMW-Ab1-42 or
HMW-Ab1-42 for 30minand thenstainedwithcalceinAM(1mM)
and ethidium homodimer-1 (2 mM) (Molecular Probes, Eugene,
OR, USA). Although the amount of green fluorescent calcein
hydrolyzed by intracellular esterase is proportional to the num-
ber of viable cells, ethidium homodimer-1 only enters cells with
damagedmembranes and binds to nucleic acids, thus producing
a bright red nuclear fluorescence relative to the number of dead
cells. Labeled cellsweremeasured at an excitationwavelength of
495 nm and emission wavelengths of 530 and 645 nm using the
SpectraMax i3 or observedunder a fluorescencemicroscope (BZ-
X800; Keyence, Osaka, Japan) to assess the viability status of
individual cells.
Water soluble tetrazolium cell viability assay
iPSCs were plated onMatrigel-coated 96-well plates with neural
medium and 1 mg/ml doxycycline, cultured for 10 d, differenti-
ated to cortical neurons as previously described, and then treated
with 10 mM of LMW-Ab1-42 or HMW-Ab1-42 for 60 min. Cell
viabilitywas assessed using thewater soluble tetrazolium (WST)
assay using Cell Count Reagent (Nacalai, San Diego, CA, USA)
according to the manufacturer’s protocol.
Detection of ROS
SH-SY5Ycellswere seededon96-well plates at a concentrationof
1 3 105 cells/ml, loaded with the ROS-sensitive dye chlor-
omethyl derivative of 29,79-dichlorodihydrofluorescein diacetate
(CM-H2DCFDA;ThermoFisherScientific) and treatedwith5mM
ofLMW-Ab1-42 orHMW-Ab1-42 for 30min.ASpectraMax i3was
used to measure the fluorescence intensity at excitation and
emission wavelengths of 488 and 525 nm, respectively. ROS ac-
cumulation is accompanied by an increase in 525 nm (green)
fluorescence intensity.
Diphenyl-1-pyrenylphosphine lipid
peroxidation assay
To detect phospholipid peroxidation in cell membranes, SH-
SY5Y cells were stained with the probe diphenyl-1-
pyrenylphosphine (DPPP; 5 mM) for 10 min at 37°C (Thermo
Fisher Scientific) before Ab treatment. DPPP is recognized to
reactwithhydroperoxides to yield fluorescent phosphine oxide
(DPPP =NO), but it is nonfluorescent until oxidized (31). After
incubationwithDPPP, cellswere exposedwith eachAb species
(5mM) for 30minandobservedunder a fluorescencemicroscope
(BZ-X800; Keyence). Peroxidation is indicated by an increase in
blue fluorescence emission.
Membrane fluidity
Membrane fluidity of SH-SY5Y cells was measured using the
lipophilic pyrene probe pyrenedecanoic acid (PDA) in the
Membrane FluidityKit (MarkerGeneTechnologies, Eugene,OR,
USA) according to the manufacturer’s protocol. In brief, 13 106
cells were exposed to 5mMof LMW-Ab1-42 or HMW-Ab1-42 and
stained at room temperature with the fluorescent lipid reagent
containing PDA, which exists as either a monomer with peak
emission at 400 nm from 360 nm excitation or as an excimerwith
peak emission near 470 nm from360 nmexcitation in response to
spatial interaction in more fluid membranes. The ratio of fluo-
rescenceemissionat 400and470nmfrom360nmexcitation (ratio
of monomer to excimer) thus serves as an estimate of membrane
fluidity. Ratio images in the membrane fluidity were calculated
by monitoring the ratio of the fluorescence signals of PDA using
confocal laser microscope Fluoview FV10i (Olympus). Briefly,
the ratio image of the fluorescence at the emissionwavelength of
excimer tomonomerwas calculated pixel by pixel anddisplayed
in grayscale.
Intracellular calcium concentration measurement
Intracellular ionized calcium concentration ([Ca2+]i) was mea-
sured using the FLIPRCalcium 5Assay Kit (Molecular Devices).
Briefly, we loaded SH-SY5Y cells with the FLIPR reagent diluted
in HBSS with 20 mM HEPES (pH 7.4) for 60 min at 37°C. Cells
were then exposed to eitherLMW-Ab1-42 orHMW-Ab1-42 (5mM)
in the presence or absence of extracellular calcium (0 mM Ca2+
HBSS with HEPES +0.3 mM EGTA). Further, after pretreatment
with L-type calcium channel antagonist 10 mM nicardipine or
10 mM nicardipine plusN-methyl D-aspartate (NMDA) receptor
antagonist 1 mMmemantine, SH-SY5Y cells were exposed with
either LMW-Ab1-42 or HMW-Ab1-42 (5 mM). In other experi-
ments, cells were incubated with either LMW-Ab1-42 or HMW-
Ab1-42 (5 mM) for 30 min and then exposed to 80 mM KCl.
Changes in [Ca2+]i were measured by observing FLIPR fluores-
cence signals at excitation and emission wavelengths of 485 and
525 nm, respectively, using Meta Xpress Image Acquisition
(Molecular Devices).
Whole-cell patch-clamp recording
SH-SY5Y cells were grown in glass-bottom dishes that were
coated with poly-D-lysine (MatTek, Ashland, MA, USA) and
used for experiments until they were 50–70% confluence. SH-
SY5Y cells were exposed to Ab (5 mM) for 30 min as indicated.
Patch electrodes (resistance 2.5–5.0MV) were made from single-
filament 1.5-mm outer diameter borosilicate capillary tubing
(GD-1.5;Narishige,Amityville,NY,USA)usingamicroelectrode
puller (P-97; Sutter Instrument, Novato, CA, USA). Electrodes
were filledwith an internal solution of the following composition
(mM) for current-clampexperiments: 130K-gluconate, 10KCl, 10
HEPES, 0.4 EGTA, 2 MgCl2, 2 Mg-ATP, and 0.3 Na2-GTP (pH
7.25, 285–300 mOsm). The external solution contained (mM)
120 NaCl, 4 KCl, 1 CaCl2, 0.3 MgCl2, 0.4 MgSO4, 0.5 NaH2PO4,
0.5 Na2HPO4, 29 NaHCO3, and 17.5 glucose. All experiments
were conducted at room temperature. Membrane potentials
were recorded in current-clamp configuration with the Multi-
clamp 700B amplifier (Molecular Devices). The data were low-
pass filtered at 10 kHz, sampled at 20 kHz (Digidata 1440;
Molecular Devices) and then analyzed on a personal computer
using pCLAMP 10.7 (Molecular Devices), Origin 2016 (Origin-
Lab, Northampton, MA, USA), and Microsoft Excel (Microsoft,
Redmond, WA, USA). Resting membrane potentials were im-
mediately registered after forming the whole-cell configuration.
Further, the liquid junction potential between bath solutions (12
mV) and pipette filling was subtracted from the membrane po-
tential values. Input resistance was measured from the record-
ings of the voltage response to hyperpolarizing currents (300 ms
in 10 pAsteps). Themembrane time constant (t)was determined
by fitting a single-exponential function to the charging transient
of the same recording. Further, membrane capacitance was cal-
culated by dividing the time constant by input resistance.
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Electrophysiological recording from the
mice hippocampus
Male C57BL/6 mice (5–7 wk old) were procured from Japan
SLC (Shizuoka, Japan) and contained in an air-conditioned
room in cages equipped with laboratory bedding under a 12
h/12 h light-dark cycle. Mice had free access to water and
were fed a commercial diet (MF; Oriental Yeast, Tokyo, Ja-
pan). The experiments were conducted according to theGuide
for Care and Use of Laboratory Animals at Toyama University
and the Guide for the Care and Use of Laboratory Animals from
the NIH.
Brains of themicewere rapidly removed, and several slices
(300 mm thickness) comprising the transverse ventral hippo-
campal region were cut in ice-cold artificial cerebrospinal
fluid (ACSF) containing (mM) 109 NaCl, 2 KCl, 1.25
MgSO4, 1.25NaH2PO4, 2CaCl2, 35NaHCO3, 20HEPES, and 25
D-glucose) using vibratome (LiniarSlicer PRO7; Dosaka EM,
Kyoto, Japan). The slices were incubated at 32°C in ACSF for at
least 120 min with constant 95% oxygen/5% carbon dioxide
aeration. Subsequently, the slice was transferred to a recording
chamber and circulated with 3ml of ACSF containing BSA (0.3
mg/ml) at 2 ml/min. Saline temperature was maintained at
34°C and continuously aerated using a gas exchange mem-
brane module (Nagasep; Nagayanagi, Tokyo, Japan). During re-
cording, the 3 ml of circulating ACSF was equilibrated using a
dialysis tube (cutoffMW: 1000;NipponGenetics, Du¨ren,Germany)
against 100 ml ACSF.
After a 15min incubationperiod in the recording chamber,we
recorded field excitatory postsynaptic potentials (fEPSPs). A bi-
polar stimulating electrode (manufactured from 2 urethane-
insulated 50 mm stainless steel wires stripped of insulation over
the distal 200 mm) was positioned on the Schaffer-collateral/
commissural bundle in the CA3 hippocampal subfield; a re-
cording glass micropipette (2–6 MV, packed with 3 mM NaCl)
was positioned on the CA1 stratum radiatum. The Schaffer-
collateral/commissural bundle was stimulated with 50 ms
monophasic square pulses at 20 s intervals. Stimulus intensity
was adjustedbetween60and200mAtoyield40%of themaximal
fEPSP amplitude (baseline stimulation). LTPwas inducedby 20 s
apart of 2 high-frequency stimulation (HFS; 100 pulses at 100Hz)
trains by the same monophasic square pulses. The evoked po-
tentials were amplified (31000), filtered (0.1–1000 Hz), digitized
(24 kHz), and stored on a computer for offline analysis with the
PowerLab system (AD Instruments, Sydney, New SouthWales,
Australia). Herein, LTP values are presented as the percentage of
the average fEPSP slope (80% of peak to bottom) relative to the
mean baseline value before HFS. In all groups, all hippocampal
sliceswerederived fromdifferentanimals. Sliceswereexposed to
LMW-Ab1-42 or HMW-Ab1-42 for 1 h before HFS.
Statistical analysis
Each measurement was repeated 3 times. The mean heights
derived from atomic force microscopy (AFM) imaging were
compared between LMW-Ab1-42 and HMW-Ab1-42 groups
using the Mann-Whitney U test. Results of all cellular exper-
iments are expressed as the means 6 SEM. The effects of vari-
ous treatments were compared to untreated SH-SY5Y cells by
1-way ANOVA followed by Dunnett post hoc test or unpaired
Student’s t test for pair-wise comparisons. Results of iPSC
assays were analyzed using ANOVA followed by Tukey post
hoc test using SPSS software (IBM SPSS, Chicago, IL, USA).
Results of synaptic transmission and LTP experiments were
analyzed by ANOVA followed by Tukey-Kramer post hoc test
using R v.3.4.3 (R Foundation for Statistical Computing,
Vienna, Austria). A value of P ,0.05 was considered statisti-
cally significant for all tests.
RESULTS
TEM and atomic force microscopy imaging
First, the assembly properties of Ab1–42 preparations
were determined using TEM and HS-AFM. The as-
semblies within the LMW andHMWSEC fractions had
morphologies consistent with those previously report-
ed (Fig. 1B, C) (22, 23, 32). The LMW-Ab1–42 fraction
consisted of irregular, globular structures of mean di-
ameter 3.78 6 0.51 nm (n = 20) that sometimes had
threadlike components (Fig. 1B) (6, 33), whereas the
HMW-Ab1–42 fraction consisted of some short, rela-
tively narrow (5 nm) structures that resembled beaded
chains, consistentwith PFmorphology (Fig. 1C) (23, 32).
AFM images also revealed structural differences be-
tween LMW and HMW. Although both fractions con-
tained globule structures (Fig. 1D, E), these differed
significantly in size, producing aggregates of distinct
individual height (Fig. 1F). The LMW-Ab1–42 was sig-
nificantly smaller than the HMW-Ab1–42 (Fig. 1F).
HMW-Ab1-42 is more cytotoxic than LMW-Ab1-42
to SH-SY5Y neuroblastoma cells
There were also substantial differences in terms of the cyto-
toxicity of these fractions. Exposure to each Ab1-42 fraction
(5mM, 30min) caused in a significant decrease in viable SH-
SY5Y cell number compared with untreated controls as
evidenced by blue formazan from MTT viable cell assay
(LMW-Ab1-42: 86.1% of control, HMW-Ab1-42: 75.8% of con-
trol, ANOVA, P, 0.01), but the reduction was significantly
greater followingHMW-Ab1-42 exposure (P, 0.05; Fig. 2A).
Neurotoxicity of each Ab1-42 fraction was further evalu-
ated by analyzing LDH activity released from dead cells
(Fig. 2B). Again, both fractions induced significant cell death
compared to untreated controls (control: 18.9%, LMW-Ab1-
42: 30.0%, HMW-Ab1-42: 37.5%, ANOVA, P , 0.01), but
HMW-Ab1-42 induced significantly greater LDH release
thanLMW-Ab1-42 (P, 0.05), indicatinggreater cytotoxicity.
To directly examine Ab cytotoxicity at the individual
cell level, SH-SY5Ycellswere stainedwith calceinAMand
ethidium homodimer-1 (Fig. 2C). Calcein AM is enzy-
matically converted to green fluorescent calcein in the
cytoplasmbyesterases of live cells,whereasonly cellswith
damaged membranes are permeable to red fluorescence
ethidium homodimer-1. Consistent with MTT and LDH
assay results, both Ab fractions increased the ethidium
homodimer-1 (dead/dying cell) to calcein (live cell) ratio
(control: 7.37%, LMW-Ab1-42: 16.43%, HMW-Ab1-42:
21.33%,P,0.01), but thedamagewassignificantlygreater
following HMW-Ab1-42 exposure than to LMW-Ab1-42
exposure (P , 0.05). Control cells remained morphologi-
cally intact as revealed by phase-contrastmicroscopy (Fig.
2D) and viable as evidenced by intense green fluorescence
emission from the cytoplasm and unstained nuclei (Fig.
2E). LMW-Ab1-42 and HMW-Ab1-42 (5 mM for 30 min)
altered cell morphology (Fig. 2F, H) and increased the
number of cells with red fluorescent nuclei, but the num-
ber of red fluorescent nuclei was significantly higher in
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cultures treated with HMW-Ab1-42 than in those treated
with LMW-Ab1-42 (Fig. 2G, I).
Finally, the greater cytotoxicity of HMW-Ab1-42 was
confirmed in iPSC-derived cortical neuronsusing theWST
assay (Fig. 2J). Exposure to HMW-Ab1-42 (10 mM for 60
min) resulted in a significantly greater decrease in WST
than both control cells and cells exposed to the same dose
of LMW-Ab1-42 (control: 100%, LMW-Ab1-42: 97.1%,
HMW-Ab1-42: 82.7%, all P, 0.05).
HMW-Ab1-42 exposure induces more severe
oxidative stress than LMW-Ab1-42 in
SH-SY5Y cells
The ROS-sensitive dye CM-H2DCFDA was used as an
indicator of ROS formation to examine the effects ofAb1-42
exposure on hydrogen peroxide production (Fig. 3A–G).
As shown in Fig. 3A, ROS generation significantly
increased in SH-SY5Y cells exposed to either Ab1-42 as-
sembly (5 mM) for 30 min or untreated control cells (con-
trol: 18.0113 105 FI/mg protein, LMW-Ab1-42: 36.393 10
5
FI/mg protein, HMW-Ab1-42: 53.54 3 10
5 FI/mg protein,
P, 0.01). Consistent with cell cytotoxicity assays, HMW-
Ab1-42 resulted in greater oxidative stress as evidenced by
the more intense green CM-H2DCFDA fluorescence than
cells treated with an equivalent dose of LMW-Ab1-42 (P,
0.05). Examples of individual untreated CM-H2DCFDA–
stained cells, those treated with LMW-Ab1-42, or those
treated with HMW-Ab1-42 are shown in Fig. 3E–G,
respectively.
Enhanced membrane lipid peroxidation
by HMW-Ab1-42
Lipid peroxidation was measured by DPPP assay in SH-
SY5Y cells after treatment with 5 mM LMW-Ab1-42 or
Figure 2. HMW-Ab1-42 is more cytotoxic than LMW-Ab1-42 to SH-SY5Y neuroblastoma cells (A–I) and iPSC-derived cortical
neurons (J ). A) MTT assay. Each value is expressed relative to the viability of untreated control cultures (set to 100%). The
formazan optical density (OD) value of the control cells was 0.3223 6 0.0098. Values are expressed as means + SEM of 12
independently treated culture wells. B) LDH assay. Values are expressed as means + SEM of 24–36 independently treated culture
wells. C) Calcein AM and ethidium homodimer-1 assay. Values are expressed as means + SEM of 24 independently treated culture
wells. D–I) SH-SY5Y cells that were observed under a phase-contrast microscope (D, F, H), and fluorescence images of calcein and
ethidium homodimer-1 staining (E, G, I). Images (D, E): Untreated control SH-SY5Y cells. Images (F, G): SH-SY5Y cells exposed to
5 mM LMW-Ab1-42. Images (H, I): SH-SY5Y cells exposed to 5 mM HMW-Ab1-42. Scale bars, 100 mm. J ) WST assay. Exposure to
HMW-Ab1-42 decreased the viability of human iPSC-derived neurons. Values are expressed as means + SEM of 6 samples
independently treated culture wells. *P , 0.05, **P , 0.01 vs. control cells. #P , 0.05, ##P , 0.01 vs. LMW-Ab1-42 group.
6 Vol. 33 August 2019 YASUMOTO ET AL.The FASEB Journal x www.fasebj.org
Downloaded from www.fasebj.org by Showa University Library (202.254.227.190) on May 13, 2019. The FASEB Journal Vol. ${article.issue.getVolume()}, No. ${article.issue.getIssueNumber()}, primary_article.
HMW-Ab1-42 (Fig. 3H–N). Again, both Ab1-42 fractions
induced significantmembranephospholipid peroxidation
compared with untreated control cells, but the severity of
peroxidation as estimated by blue fluorescence intensity
was greater following HMW-Ab1-42 treatment (control:
111.9 3 105 FI/mg protein, LMW-Ab1-42: 130.9 3 10
5 FI/
mg protein, HMW-Ab1-42: 170.33 10
5 FI/mg protein, P,
0.01 vs. control, P , 0.05 vs. LMW-Ab1-42) (Fig. 3H).
Fluorescence images of individual DPPP-stained cells
during Ab1-42 exposure are presented in Fig. 3L–N.
HMW-Ab1-42 has greater effects on cell
membrane fluidity than LMW-Ab1-42
Membrane phospholipid peroxidation is assumed to
alter multiple membrane structural and function
properties including barrier function, fluidity, and lipid
raft properties. Figure 4 shows that both HMW-Ab1-42
and LMW-Ab1-42 (5 mM, 30 min) significantly reduced
SH-SY5Y cell membrane fluidity compared with non-
treated control cells (control: 100 6 3.72%, LMW-Ab1-42:
83.3 6 4.3%, HMW-Ab1-42: 70.7 6 4.99%, P , 0.01 vs.
control). Furthermore, HMW-Ab1-42 produced a larger
decrease in fluidity than did LMW-Ab1-42 (P , 0.05).
Consistentwith the results of the cell membrane fluidity
assay, HMW-Ab1-42 led to a decrease in membrane
fluidity as evidenced by a darker black level of ratio
image than untreated cells. Individual ratio images of
cells treated untreated, treated with LMW-Ab1-42, or
treated with HMW-Ab1-42 are shown in Fig. 4C, E, G,
respectively.
Intracellular Ca2+ dysregulation following
LMW-Ab1-42 and HMW-Ab1-42 exposure
We next investigated the effects of LMW-Ab1-42 and
HMW-Ab1-42 on [Ca
2+]i homeostasis using Meta Xpress
Image Acquisition (Fig. 5).
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Figure 3. HMW-Ab1-42 induces more severe oxidative stress and membrane lipid peroxidation than LMW-Ab1-42 in SH-SY5Y cells.
A) ROS generation. Each value represents the mean + SEM of 12 independently treated culture wells. *P, 0.01 vs. control cells. #P
, 0.05 vs. LMW-Ab1-42 group. B–G) The SH-SY5Y cells observed using a phase-contrast microscope (B–D) and CM-H2DCFDA
fluorescence (E–G), untreated SH-SY5Y cells (B, E), SH-SY5Y cells exposed to 5 mM LMW-Ab1-42 (C, F), SH-SY5Y cells exposed to
5 mMHMW-Ab1-42 (D, G). Scale bars, 200 mm. H) DPPP assay. Each value represents the mean6 SEM of 12 independently treated
culture wells. *P , 0.01 vs. control cells. #P , 0.05 vs. LMW-Ab1-42 group. I–N) The SH-SY5Y cells were observed under a phase-
contrast microscope (I–K), DPPP fluorescence (L–N), untreated SH-SY5Y cells (I, L), SH-SY5Y cells exposed to 5 mM LMW-Ab1-42 (J,
M). SH-SY5Y cells exposed to 5 mM HMW-Ab1-42 (K, N). Scale bars, 100 mm.
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Exposure of SH-SY5Y cells to LMW- or HMW-Ab1-42
triggered an elevation in [Ca2+]i. This increase reached a
peak in;10safter exposureand [Ca2+]i remainedelevated
at a nearly constant plateau level thereafter (Fig. 5A). The
peak increase did not differ significantly between LMW-
Ab1-42 and HMW-Ab1-42 treatments, but the plateau level
was higher in cells exposed to HMW-Ab1-42 (after 60 s of
exposure, LMW-Ab1-42: 106.87 6 1.38%, HMW-Ab1-42:
112.31 6 1.84%, P , 0.05). To confirm that this [Ca2+]i
increasewasbecause of influx,wealsomeasured [Ca2+]i in
the absence of extracellular Ca2+. Removal of extracellular
Ca2+ completely inhibited the [Ca2+]i increase evoked by
5 mM LMW- or HMW-Ab1-42 (Fig. 5A), indicating that
Ab1-42 exposure induces extracellular Ca
2+ influx.
To investigate whether this Ca2+ influx is mediated by
L-type calcium channels, [Ca2+]i changes in response to
LMW- andHMW-Ab1-42 stimulation were also measured
in the presence of the L-type voltage-dependent Ca2+
channel (VDCC) blocker nicardipine. Pretreatment with
nicardipine (10 mM) caused significant decrease in the
[Ca2+]i elevation measured after 75 s of HMW-Ab1-42
(5 mM) exposure (HMW-Ab1-42: 1106 2.03%, nicardipine
pretreatment: 105.4 6 1.28%, P , 0.05 vs. HMW-Ab1-42)
(Fig. 5B). These findings suggest that HMW-Ab1-42 pro-
motes calcium influx through L-type VDCCs in SH-SY5Y
cells. Furthermore, in exposure to LMW-Ab1-42 or HMW-
Ab1-42, pretreatment with nicardipine (10 mM) plus
memantine (1 mM) resulted in a marked reduction of
[Ca2+]i compared to pretreatment with nicardipine alone
(after 25 s of HMW-Ab1-42 exposure: nicardipine pre-
treatment: 117.3 6 1.09%, nicardipine plus memantine
pretreatment: 103.9 6 0.94%, P , 0.01 vs. pretreatment
with nicardipine) (Fig. 5B). Memantine modulates the
glutamatergic system, likely by blocking Ca2+ influx
through NMDA receptors.
We next investigated the effects of LMW-Ab1-42 and
HMW-Ab1-42 pre-exposure (5 mM for 30 min) on in-
tracellular calcium homeostasis in SH-SY5Y cells. The ex-
posure to 80mMKCl, known to cause depolarization and
Ca2+ entry viaVDCCs, resulted in increased [Ca2+]i in SH-
SY5Y cells (Fig. 5C). However, KCl-induced [Ca2+]i in-
creases were significantly reduced by pre-exposure to
LMW- or HMW-Ab1-42 compared with Ab1-42-untreated
cells (after 19.5 s of exposure to 80mMKCl alone: 144.426
2.69%,plusLMW-Ab1-42: 112.836 4.52%,P, 0.05vs.KCl,
plus HMW-Ab1-42: 113.986 9.90%, P, 0.01 vs.KCl). This
suppression of depolarization-evoked [Ca2+]i elevation
was greater in the presence of HMW-Ab1-42 than LMW-
Ab1-42 (after 45.5 s of exposure, LMW-Ab1-42: 212.39 6
6.39%, HMW-Ab1-42: 163.8 6 14.8%, P , 0.05). Overall,
these findings suggest that an exposure toAb1-42 damages
voltage-gated calcium channels, reduce their membrane
insertion, or decrease voltage-gated activity due to
changes in the membranes structure.
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observed under a phase-contrast microscope are shown in B, D,
and F. Ratio image of fluorescence is shown in C, E, and G. SH-
SY5Y cells exposed to 5 mM LMW-Ab1-42 (D, E), SH-SY5Y cells
exposed to 5 mM HMW-Ab1-42 (F, G). Scale bars, 10 mm.
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Sustained depolarization of the SH-SY5Y cell
membrane potential following exposure to
LMW-Ab1-42 or HMW-Ab1-42
In light of results showing disruption of membrane in-
tegrity, we examined the passive membrane electrophys-
iological properties (resting potential, input resistance,
time constant, and whole-cell capacitance) of SH-SY5Y
cells exposed to 5mMLMW-Ab1-42 orHMW-Ab1-42 for 30
min. Figure 6 shows representative traces in response to
400mshyperpolarizinganddepolarizing currentpulses in
untreated cells and cells exposed to each Ab assembly
type. The resting potential was significantly elevated in
SH-SY5Y cells exposed to HMW-Ab1-42 (5 mM) compared
with untreated control cells and LMW-Ab1-42–exposed
cells (control:245.886 0.92 mV, LMW-Ab1-42:245.146
0.88 mV, HMW-Ab1-42: 242.70 6 0.67 mV, P , 0.05 vs.
control, P , 0.05 vs. LMW-Ab1-42) (Fig. 6D). Furthermore,
input resistance was significantly lower following HMW-
Ab1-42 exposure (control: 3575.96213.59MV,LMW-Ab1-42:
3404.2 6 232.42 MV, HMW-Ab1-42: 2475.7 6 191.16 MV,
P , 0.05 vs. control, P , 0.05 vs. LMW-Ab1-42; Fig. 6E).
However,whole-cell capacitance did not significantly differ
among treatment groups (control: 24.2 6 1.22 pF, LMW-
Ab1-42: 26.036 1.39 pF, HMW-Ab1-42: 22.526 1.67 pF; Fig.
6F). These data suggest that HMW-Ab1-42 induces greater
passive membrane ion leakage than does LMW-Ab1-42,
consistent with vital staining results.
HMW-Ab1–42 impairs hippocampal LTP
Finally, we examined the effects of LMW-Ab1–42 and
HMW-Ab1–42 on basal synaptic transmission and HFS-
induced LTP in the CA1 subfield of hippocampal slices
(Fig. 7). In the Schaffer-collateral/commissural pathway,
neither LMW-Ab1–42 nor HMW-Ab1–42 (1mM for 60min)
altered the strength of electrically evoked basal synaptic
transmission as measured by the ratio of fEPSP slope in
treated slices compared with untreated control slices
[control: 1036 4% (n = 9), LMW-Ab1–42: 1006 3% (n = 6),
HMW-Ab1–42: 986 4% (n= 7); F2, 19 = 0.445,P= 0.647; Fig.
7A, B].
Figure 5. HMW-Ab1-42 more strongly inhibits depolarization-evoked Ca
2+-influx than LMW-Ab1-42. Effects of LMW-Ab1-42 and
HMW-Ab1-42 on [Ca
2+]i in SH-SY5Y cells. A) Changes in [Ca
2+]i were measured fluorometrically in untreated SH-SY5Y cells and in
cells exposed to 5 mM LMW-Ab1-42 or HMW-Ab1-42. Arrow indicates the addition of Ab1-42 to SH-SY5Y cells. Changes in [Ca
2+]i
during exposure to 5 mM LMW-Ab1-42 or HMW-Ab1-42 were also examined in Ca
2+-free buffer. B) SH-SY5Y cells were pretreated
with 10 mM nicardipine (Nica) or 10 mM Nica +1 mM memantine (Mem) for 5 min or left untreated, followed by exposure to
LMW-Ab1-42 or HMW-Ab1-42. Arrows indicate the addition of Ab1-42 to the SH-SY5Y cells. Nica significantly reduced the Ab1-42-
induced [Ca2+]i increase (after 75 s; P , 0.05). Furthermore, alterations in [Ca
2+]i levels by exposure to LMW-Ab1-42 or HMW-
Ab1-42 after pretreating the cells with Nica + Mem showed a significant decrease compared to Nica pretreatment (25–70 s; P ,
0.01). C) Increases in [Ca2+]i evoked by 80 mM KCl in SH-SY5Y cells exposed to 5 mM LMW-Ab1-42 or HMW-Ab1-42 for 30 min.
Arrow indicates the addition of 80 mM KCl.
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We next tested the effects of each Ab1–42 assembly on
hippocampal LTP (Fig. 7A,C). At 50–60min afterHFS, the
ratio of the fEPSP slope relative to the control group was
not significantly reduced by LMW-Ab1–42 but was sig-
nificantly lower in slices treated with HMW-Ab1–42 [con-
trol: 176 6 9% (n = 12 slices from 12 mice), LMW-Ab1–42:
1666 14% (n = 7 slices from 7mice), HMW-Ab1–42: 1386
10% (n = 8 slices from 8 mice); F2, 23 = 3.86, P = 0.036; Fig.
7A, C]. Thus, HMW-Ab1-42, but not LMW-Ab1–42, signif-
icantly reduced LTP formation (P, 0.05).
DISCUSSION
Although recent evidence suggested that low-order olig-
omers such as dimers, trimers, andHMW oligomers such
as PFs exhibit cellular and synaptic toxicities (1, 3–6), the
pathogenic mechanisms for Ab-induced cell dysfunction
and death in AD remain controversial, at least in part,
because the relative toxicities of variousAb conformations
are unclear. Nonetheless, numerous studies have dem-
onstrated the disruption of organelle and cellular homeo-
stasis by Ab aggregates, which in turn can trigger or
exacerbate excitotoxicity, oxidative stress, calcium dysre-
gulation, and a shift in the balance between pro- and
antiapoptotic factors (34). Actually, assemblies including
Ab-derived diffusible ligands, HMWoligomers, and low-
order oligomers are found in cerebrospinal fluid (35),
plasma (36), and interstitial fluid (37) of patients with AD,
but it is unclear how brain cells exposed to Ab oligomers
become dysfunctional and deteriorate. One unifying ex-
planation is the potential effect of Ab oligomers on mem-
branes that affects plasma membrane permeation and
causes mitochondrial dysfunction and lysosomal leakage,
resulting in effects such as loss of ionic gradients, plasma
membrane potential, and mitochondrial membrane
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potential and metabolic uncoupling. Although there are
studies suggesting the disruption of membrane integrity
by Ab (38), definitive conclusions are hindered by the
differences in experimental conditions and peptide
preparation.
To elucidate the dominant mechanisms of Ab
oligomer–induced neuronal damage, including mem-
brane damage, we studied the cellular responses to
LMW andHMW-Ab oligomer exposure usingmultiple
indices of membrane integrity, cytolysis, oxidative
stress, and synaptic function. We found that cell mem-
brane and metabolic integrity were more severely dis-
rupted byHMW-Ab1-42 than LMW-Ab1-42 as evidenced
by the MTT cell viability assay, LDH leakage assay,
calcein and ethidium homodimer-1 (live/dead) cell
staining, WST assay, fluorometric measure of ROS
generation and [Ca2+]i, lipid peroxidation assays,
membrane fluidity measures, and electrophysiological
recordings. Results of LDH and calcein and ethidium
homodimer-1 assays that reflect cell membrane damage
were clearly different between LMW-Ab1-42 and HMW-
Ab1-42, but in the MTT and WST assays that reflect mi-
tochondrial enzyme activity, the difference between
both Abs was not big. From these results, in short-term
Ab1-42 treatment, Ab1-42 may first attack the cell mem-
brane and subsequently induce damage to mitochon-
dria. The degree of cell membrane damage was more
severe in HMW-Ab1-42 than LMW-Ab1-42.
Manystudieshavereported thatoxidative stress,which
occurs in the presence of a physiologic imbalance between
ROS generation and antioxidant capacity, is a critical
pathogenic mechanism in AD progression (39). Indeed, in
the brains of patients at different AD stages, increased
oxidative stress marker levels are present (40). For exam-
ple, the levels of lipid peroxide markers such as 4-
hydroxyhexenal are constantly elevated during the early
mild cognitive impairment and preclinical AD stages
compared with healthy control subjects and patients with
late-stage AD (41). Along with the direct destruction/
modification of lipids, DNA and proteins, the byproducts
of lipid peroxidation produced during oxidative stress
cause damage to the mitochondria and up-regulate tau
phosphorylation, which appears essential for NFT for-
mation (42). Because the redoxproperties of thesedifferent
Ab conformations are complex, the mechanisms of ROS
generation in AD are unclear. The contribution of Ab to
oxidative stress is suggested by its metal-binding capacity
(particularly for Cu2+) and its ability to reduce Cu2+ and
Fe3+ to Cu+ and Fe2+, which can then catalyze the gener-
ation of highly reactive superoxide anions from H2O2 via
the Fenton reaction (43). Indeed, Ab-induced ROS gener-
ation has been repeatedly demonstrated using various
detection methods (44, 45). Generation of superoxide by
Ab may lead to mitochondrial impairment and further
ROS generation, thereby establishing a positive feedback
pathway that ultimately results in cell death (46). Gunn
et al. (8) reported that Cu2+-oxidized small oligomers of
Ab1-42 bind to neurons and cause loss of plasma mem-
brane integrity through lipid peroxidation. Further, Ab
may directly interact with the mitochondrial respiratory
chain, causing metabolic dysfunction and increased ROS
production (47), which is consistent with the clinical ob-
servations related to mitochondrial oxidative damage
with AD progression (39). Fluorescent dye studies using
model membranes have reported that aggregated Ab
damages cells by reducing membrane fluidity (48, 49),
whereas it was recently reported that small Ab oligomers
had the opposite effect by reducingmembrane cholesterol
content (50). In the current study, we report that HMW-
Ab1-42 reduces the fluidity of neuronal membranes to a
significantly greater extent than LMW-Ab1-42. Thus, it is
possible that the influence on membrane fluidity and en-
suing neuronal damage depends on the specific Ab
conformation.
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exposure. C) fEPSP slopes 50–60 min after HFS. Bars and scattered circles indicate medians and individual experimental values,
respectively. *P , 0.05, control vs. HMW-Ab1-42 group.
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The effect of LMW-Ab1-42 and HMW-Ab1-42 was not
different in the peaks immediately after exposure, how-
ever, at subsequent sustained plateau levels of [Ca2+]i,
HMW-Ab1-42 exposure maintained higher levels than
those induced by LMW-Ab1-42. On the other hand, we
observed reduced depolarization-induced [Ca2+]i influx
through voltage-dependent Ca2+ channels following
longer HMW-Ab1-42 treatment. These results suggested
that HMW-Ab1-42 may not only damage voltage-gated
calcium channels directly for a short time but also alter the
cell membrane environment required for proper channel
insertion or gating for a long time as evidenced by lipid
peroxidation and membrane fluidity measurements.
Pretreatmentwith nicardipine significantly decreased the
HMW-Ab1-42-induced increase in [Ca
2+]i, suggesting that
HMW-Ab1-42 promotes calcium influx through L-type
VDCCs and that cells are not able to appropriately buffer the
increase. Furthermore, pretreatment with nicardipine plus
memantine resulted in a marked reduction of [Ca2+]i com-
pared topretreatmentwithnicardipinealone.These findings
suggest that both Abs promotes calcium influx through
L-type VDCC and NMDA receptors in SH-SY5Y cells.
However, nicardipine plus memantine did not completely
suppress the Ab1-42-induced [Ca
2+]i increase, suggesting
activation of other influx or release pathways. It is reported,
for example, thatAb1-42 oligomermay activate thea-amino-
3-hydroxy-5-methyl-4-isoxazolepropionic acid receptor and
store-operated calcium channel (14). Furthermore, NMDA
receptor activity could be promoted by Ab1-42-evoked de-
polarization. A sustained increase in [Ca2+]i by Ab1-42 may
also cause mitochondrial Ca2+ overload, which in turn
would promote the generation of ROS such as superoxide
radicals. In addition, the release of apoptosis-inducing mi-
tochondrial proteins including cytochrome c and increased
[Ca2+]i have been suggested to be the major effectors of
neuronal cell death or neurodegeneration in several AD
models (51).
Ca2+ homeostasis disruption is recognized as a poten-
tial mechanism related to AD neurodegeneration. It has
been shown that elevated [Ca2+]i results from both tau
phosphorylation and mitochondrial damage, leading to
further increases in ROS and [Ca2+]i and finally to cell
death (52). The increase in ROS generation and lipid per-
oxidation as well as the decrease in membrane fluidity
induced by Ab oligomers promote Ca2+ influx through
VDCCs and NMDA receptors (14, 53). In addition, Ab
oligomers have been suggested to have the ability of
penetrating and inserting into membranes, coating or ly-
ing on membrane surfaces, and potentially acting as cell-
penetrating peptides (38). The detergent‐like permeation
of Ab peptide into lipid membranes is suggested to occur
by the association of amyloid‐forming peptides inmicelle‐
like structures. Further,membranepermeation takes place
at high local peptide concentrations on the membrane
surface after the covering of the surface with peptide
monomers or oligomers or by an association between
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Figure 8. Schematic representation of Ab neurotoxicity through membrane disruption. Although the various isoforms of
aggregated Ab are related to the pathogenesis of AD, oligomers such as HMW-Ab1-42 are more damaging to neuronal
membranes than LMW-Ab1-42.
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membrane‐bound amyloid fibrils (54). It has been recently
suggested that small oligomers of Ab have higher affinity
for HEK293T cell membranes than monomers (21), which
is consistent with the greater cytotoxicity of HMW-Ab1-42
than LMW-Ab1-42. The initial interaction may be electro-
statically driven, whereby Ab preferentially binds to lipid
headgroups or receptors on the membrane surface (55).
Ab can insert directly into lipid bilayers and form pores, a
phenomenon first observed with artificial membranes
(18). Similarly, Ab1-42 can assemble into a pore-forming
b-barrel Ab oligomeric structure, whereas Ab1-40 aggre-
gates into amyloid fibrils under optimized detergent mi-
celle conditions (20). Recently, it was reported that Ab
oligomers can irreversibly insert into the membrane and
spontaneously form ion channels (19), and a recent simu-
lation study indicated that membrane lipid peroxidation
promotes this pore formation (56). Extracellular applica-
tion of sphericalAb1-42 oligomers caused a large and rapid
[Ca2+]i elevation concomitant with increased membrane
permeability in SH-SY5Y cells and oocytes (13, 57). Indi-
vidual Ab oligomers larger than trimers reportedly in-
ducedCa2+ entryby crossing theplasmamembrane rather
than by acting on cellular receptors (58). Thus, the toxicity
associated with Ab oligomers may involve numerous
distinct mechanisms, including effects on specific mem-
brane proteins and general lipid damage, depending on
conformation, concentration, cell type, and cell status.
Nonetheless, disruptionof biologicmembranes appears to
be a common pathogenic mechanism for different Ab
aggregation states.
Consistent with the changes in [Ca2+]i and loss of
membrane integrity, application of HMW-Ab1-42, but not
LMW-Ab1-42, also depolarized SH-SY5Y cells and signifi-
cantly reducedmembrane input resistance. Bode et al. (59)
monitored transmembrane currents during Ab exposure
to the extracellular face of the excised membranes from
HEK293 cells and found that circular small Ab1-42 oligo-
mers formed ion channels, whereas Ab1-40 oligomers, as
well as fibrils andmonomers, didnot.Drolle et al. (60)used
multicomponent lipid models with the aim to mimic
healthyandADstatesofneuronalmembranesandposited
that Ab1-42 increases lipid membrane roughness and in-
creases membrane conductance, possibly through pore
formation. Taken together, the [Ca2+]i increase evoked by
Ab1-42 oligomers may be due to pore formation and oxi-
dative damage as well as suppression of calcium egress
and sequestration pathways secondary to metabolic
disruption.
Finally, we demonstrated that HMW-Ab1-42 signifi-
cantly inhibited LTP formation in themouse hippocampal
CA1subfield.BothLMWandHMWoligomersofAbhave
been reported to suppress LTP (5, 7), which may contrib-
ute to cognitive impairment that is observed in the early
stages of AD before neurodegeneration (61). Excessive
ROS accumulation reportedly inhibits LTP (62). In addi-
tion, membrane fluidity has been implicated in LTP and
learning (63) and decreases in aged animals with learning
and LTP deficits (64). These findings suggest that ROS
generation and decreased membrane fluidity induced by
HMW-Ab impair the molecular, cellular, and synaptic
properties essential for learning. Furthermore, membrane
pore formation may also impair cellular and synaptic
functions (65, 66), and it is consistent with the observed
loss of membrane integrity demonstrated by MTT, LDH,
and calcein/ethidium homodimer-1 assays, [Ca2+]i ele-
vation, resting membrane potential increase, input re-
sistance decrease, and LTP impairment. Taken together,
our results demonstrated multiple mechanisms of Ab
oligomer–induced neuronal injury and death (Fig. 8).
Our findings suggest the possibility that reduction of
HMW-Ab1-42 assemblies, such as PFs, may inhibit AD-
associated neuronal damage by not only suppressing Ab
plaque accumulation but also reducing the direct mem-
brane toxicity of HMW-Ab1-42.
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